Discover
CYCN
Cyclerion Therapeutics, Inc.
23.52
2 x 2.52
2 x 4.09
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
3.47 -20.05 (85.25%)
| Ytd | 164.57% | |
| 1y | 48.67% |
2.82
day range
23.52
2.82
52 week range
59.36
| Open | 3.72 | Prev Close | 23.52 | Low | 2.82 | High | 23.52 | Mkt Cap | 15.73M |
| Vol | 435.85K | Avg Vol | 6.83K | EPS | -11.62 | P/E | N/A | Forward P/E | -2.44 |
| Beta | 1.92 | Short Ratio | 0.78 | Inst. Own | 40.41% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 26.37 | 200-d Avg | 18.35 | 1yr Est | 4.00 |
| Income Statement | |||
| Operating Expenses | 1.77M | ||
| Selling, General and Administrative Expense | 1.77M | ||
| Operating Income | -1.77M | ||
| Net Income | -1.75M | ||
| Net Income Common Stock | -1.75M | ||
| Net Income Common Stock (USD) | -1.75M | ||
| Consolidated Income | -1.75M | ||
| Earnings per Basic Share | -2.87 | ||
| Earnings per Basic Share (USD) | -2.87 | ||
| Earnings per Diluted Share | -2.87 | ||
| Earning Before Interest & Taxes (EBIT) | -1.75M | ||
| Earning Before Interest & Taxes (USD) | -1.75M | ||
| Weighted Average Shares | 607.00K | ||
| Weighted Average Shares Diluted | 607.00K | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.39M | ||
| Cash and Equivalents (USD) | 1.39M | ||
| Investments | 5.35M | ||
| Investments Non-Current | 5.35M | ||
| Current Assets | 1.51M | ||
| Property, Plant & Equipment Net | 66.00K | ||
| Total Assets | 6.93M | ||
| Current Liabilities | 1.84M | ||
| Total Liabilities | 1.84M | ||
| Accumulated Retained Earnings (Deficit) | -275.95M | ||
| Shareholders Equity | 5.09M | ||
| Shareholders Equity (USD) | 5.09M | ||
| Assets Non-Current | 5.42M | ||
| Trade and Non-Trade Payables | 1.60M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.43M | ||
| Net Cash Flow from Operations | -1.43M | ||
| Share Based Compensation | 51.00K | ||